GSK3 Inhibitors and Disease

Author(s): Felix Hernandez, Javier Diaz Nido, Jesus Avila, Nieves Villanueva

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 9 , Issue 9 , 2009

Become EABM
Become Reviewer
Call for Editor


This review describes, briefly, the characteristics and regulation of glycogen synthase kinase 3 (GSK3) together with the role of GSK3 dysfunctions in different pathologies, and GSK3 as target for therapeutic treatment in different diseases. Several GSK3 inhibitors acting at different levels are described in this work, ranging from cations like lithium to small compounds developed by different pharmaceutical companies. Also, the use of specific interference RNA (iRNA) for the specific inhibition of the expression of the different GSK3 isoforms is discussed.

Keywords: GSK3, lithium, Alzheimer, neurodegeneration

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [1024 - 1029]
Pages: 6
DOI: 10.2174/138955709788922647
Price: $65

Article Metrics

PDF: 13